Cardinal Health financials
$220.29+0.03%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '26 Jun 30 | Q3 '26 Mar 31 | Q2 '26 Dec 31 | Q1 '26 Sep 30 | Q4 '25 Jun 30 | Q3 '25 Mar 31 | Q2 '25 Dec 31 | Q1 '25 Sep 30 | Q4 '24 Jun 30 | Q3 '24 Mar 31 | Q2 '24 Dec 31 | Q1 '24 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $63.67B | $60.94B | $65.63B | $64.01B | $60.16B | $54.88B | $55.26B | $52.28B | $59.87B | $54.87B | $57.44B | $54.65B |
| Gross profit | $2.56B | $2.50B | $2.40B | $2.32B | $2.20B | $2.12B | $1.94B | $1.90B | $1.88B | $1.94B | $1.85B | $1.74B |
| Gross margin | 4.0% | 4.1% | 3.7% | 3.6% | 3.7% | 3.9% | 3.5% | 3.6% | 3.1% | 3.5% | 3.2% | 3.2% |
| Operating income | $733.0M | $694.0M | $707.0M | $670.0M | $461.0M | $713.0M | $549.0M | $567.0M | $401.0M | $369.0M | $505.0M | $509.0M |
| Net income | $398.0M | $399.0M | $467.0M | $450.0M | $239.0M | $506.0M | $400.0M | $416.0M | $235.0M | $261.0M | $368.0M | -$12.0M |
| Net margin | 0.6% | 0.7% | 0.7% | 0.7% | 0.4% | 0.9% | 0.7% | 0.8% | 0.4% | 0.5% | 0.6% | 0.0% |
| Diluted EPS | $1.69 | $1.69 | $1.97 | $1.88 | $1.00 | $2.10 | $1.65 | $1.70 | $0.95 | $1.07 | $1.50 | $-0.05 |
| EBITDA | $1.01B | $978.0M | $930.0M | $923.0M | $688.0M | $843.0M | $722.0M | $733.0M | $812.0M | $763.0M | $698.0M | $665.0M |
| Operating cash flow | $1.69B | $1.82B | $686.0M | $973.0M | $1.52B | $2.92B | -$396.0M | -$1.65B | $2.08B | -$27.0M | $1.18B | $528.0M |
| Free cash flow | $1.43B | $1.68B | $555.0M | $865.0M | $1.29B | $2.79B | -$495.0M | -$1.74B | $1.89B | -$139.0M | $1.06B | $436.0M |
| Diluted shares | 236.0M | 236.0M | 237.0M | 239.0M | 239.0M | 241.0M | 243.0M | 245.0M | 248.0M | 245.0M | 246.0M | 249.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.86B | $3.94B | $2.78B | $4.59B | $3.87B | $3.33B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $8.89B | $8.92B | $9.03B | $9.03B | $8.53B | $7.68B |
| Total assets | $57.30B | $56.69B | $58.08B | $55.23B | $53.12B | $49.87B |
| Total liabilities | $60.02B | $59.36B | $60.78B | $57.96B | $55.76B | $51.77B |
| Shareholders' equity | -$2.72B | -$2.67B | -$2.70B | -$2.73B | -$2.63B | -$1.90B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology